Filing Flows › Maravai Lifesciences Holdings (MRVI) › Guidance history
Maravai Lifesciences Holdings (MRVI) guidance history: what it guided and what it reported
Maravai Lifesciences Holdings gave guidance in 3 earnings releases on file since May 7, 2026. Its releases raised guidance 3 times and lowered it 0 times.
Revenue
Every guided period is still to be reported.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $205M–$215M (May 7, 2026) → reaffirmed $205M–$215M (Aug 6, 2026) → raised $212M–$216M (Nov 4, 2026) | — | to be reported | — |
Adjusted EBITDA
Every guided period is still to be reported.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $30.0M–$32.0M (May 7, 2026) → raised $33.0M–$35.0M (Aug 6, 2026) → raised $40.0M–$42.0M (Nov 4, 2026) | — | to be reported | — |
The latest quarter
Maravai Lifesciences Holdings, Q3 2026: revenue $45.9M (+10% year over year), operating margin -45.0%, net loss $24.0M, operating cash flow $5.0M. The chart follows the revenue to costs, profit and cash.
Questions
Does Maravai Lifesciences Holdings beat its guidance?
Maravai Lifesciences Holdings gave guidance in 3 earnings releases on file since May 7, 2026. Its releases raised guidance 3 times and lowered it 0 times.
How often does Maravai Lifesciences Holdings raise guidance?
Its earnings releases raised guidance 3 times and lowered it 0 times since May 7, 2026.
Each guided period is held to the last guidance given before its figures were reported; a single figure counts as in line within 1% (0.25 pts for a rate). Reported figures are GAAP, from the company's filings; adjusted guidance shows its moves only.